Description
GAD65 is one of the major autoantigens in Type 1 Diabetes (T1D). Autoreactive T cells can be detected in PBMC from T1D or at-risk subjects after a primary culture with several immunodominant GAD65 peptides. Ignyte Bio offers Anti-GAD65 CD4 T cells with specificity to GAD65 (274-286) peptide and restricted by HLA-DRB1*04.